Clinical Trial Update: Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice

View source ↗

Summary

The study reports efficacy and safety results of Humira (adalimumab) in patients with psoriatic arthritis treated in routine clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Psoriatic Arthritis | Status: COMPLETED | Results posted: 2014-12-30